5d 1m 3m 1y 5y 10y
There are 3 articles on this stock available only to PRO subscribers.
Marketwire (Mar 31, 2014)
Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for Probuphine Clinical StudyMarketwire (Mar 3, 2014)
TTNP vs. ETF Alternatives
Titan Pharmaceuticals, Inc is a biopharmaceutical company focused in the development of products for the treatment of central nervous system (CNS) diseases.
Country: United States
Friday, Sep 272013, 2:20 PM
Friday, Sep 272013, 2:20 PM| 1 Comment
- Titan Pharmaceuticals (TTNP.OB +16.4%) rallies on huge volume.
- The FDA has granted the company a Type C meeting for November 19 to discuss exactly what went wrong with the Probuphine NDA.
- The company hopes the meeting will provide some "clarity regarding the regulatory path forward" for the buprenorphine implant. (PR)
- The stock collapsed in May when the company received the CRL.
Wednesday, May 12013, 9:56 AMTitan Pharmaceuticals (TTNP.OB -75.9%) loses more than three quarters of its market value after the FDA rejects its experimental opioid addiction treatment Probuphine. The company says it is "extremely surprised and disappointed" — shareholders likely feel the same. (See SA contributor Brian Wilson's opinion piece for more) |Wednesday, May 12013, 9:56 AM| 2 Comments
Monday, Mar 252013, 4:40 PMTitan Pharmaceuticals (TTNP.OB +7.8%) extends gains Monday after rising more than 30% Friday on news the FDA has recommended approval of the company's opioid addiction drug Probuphine. Investors however, are no doubt still stinging from the ~40% dive the stock took last Tuesday. |Monday, Mar 252013, 4:40 PM| Comment!
Friday, Mar 222013, 12:11 PMShares of Titan Pharmaceuticals (TTNP.OB +35%) rise dramatically after the company says the FDA recommends approval for its opioid addiction treatment drug Probuphine. The terms of a licensing agreement announced last year indicate Titan will receive $50M from its commercialization partner Braeburn Pharmaceuticals upon FDA approval. |Friday, Mar 222013, 12:11 PM| 2 Comments
- View all 1 replies
Tshar:: I am getting on the hype train till November meeting then going to sell, with another buy limit order in case positive news results.
- View all 1 replies
FRany:: will be in higher levels soon. Big news coming. Strong buy